The NEOMUNE research platform provides results at biological, societal and commercial levels.
At the biological level, NEOMUNE investigates diet and microbiota interventions that may support infection resistance, nutrient uptake capacity and some selected brain functions in infants.
The societal analyses will help us understand the treatment limitations in the different cultural, ethical and economic environments.
At the commercial levels, NEOMUNE will develop new infant diets and gut microbiota treatments for newborn infants.
Scientific results, both positive and negative, will published in international, recognized journals with relevant review competence and readership.